Diversity in Dermatology Clinical Trials A Systematic Review

被引:102
|
作者
Charrow, Alexandra [1 ]
Di Xia, Fan [2 ]
Joyce, Cara [3 ]
Mostaghimi, Arash [4 ]
机构
[1] Harvard Med Sch, Harvard Combined Dermatol Residency Training Prog, Boston, MA USA
[2] Harvard Med Sch, Brigham & Womens Hosp, Boston, MA USA
[3] Walgreen Co, Deerfield, IL USA
[4] Harvard Med Sch, Dept Dermatol, Brigham & Womens Hosp, Boston, MA USA
关键词
RACE; CANCER; REPRESENTATION; ASSOCIATION; MINORITIES; SEX;
D O I
10.1001/jamadermatol.2016.4129
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
IMPORTANCE Though there have been significant shifts in US demographic data over the past 50 years, research cohorts lack full racial and ethnic representation. There is little data available regarding the diversity of dermatology research cohorts with respect to sex, race, and ethnicity. OBJECTIVE To characterize and assess the representation of racial and ethnic minorities and women in randomized controlled trials across a range of dermatologic conditions. EVIDENCE REVIEW All randomized clinical trials (RCTs) were identified between July 2010 and July 2015 within the PubMed database using the followingkeywords: "psoriasis," " atopic dermatitis," "acne," "vitiligo," "seborrheic dermatitis," "alopecia areata," and " lichen planus." Diverse study populations were defined as including a greater than 20% racial or ethnic minority participants based on US census data. The distributions of sex and race groups in studies were compared by journal type, disease type, and funding source. FINDINGS Of the 626 articles reporting RCTs included in this analysis, 532 (85.0%) reported the sex of study participants. Overall, 52 of 626 international (11.3%) studies and 58 of 97 studies (59.8%) conducted exclusively within the United States reported on the racial or ethnic demographics of study participants. Across all RCTs exclusively recruited within the United States that reported race, 74.4% of study participants were white. Disease type was significantly associated with the degree of racial diversity (P <.001) within a study cohort: 30.0% of US-based psoriasis had more than 20% racially or ethnically diverse research participants as compared with 73.9% of acne studies and 91.7% of eczema studies. CONCLUSION AND RELEVANCE Dermatologic clinical trials within the United States reflect the growing diversity of the US population. Reporting of both sex and racial/ethnic diversity of research cohorts is still lacking, especially among studies conducted outside of the United States.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 50 条
  • [1] Trends in diversity of participants in dermatology clinical trials over time: A systematic review
    Ferguson, Jessica E.
    Vetos, Develyn
    Ho, Bao Vincent
    Aziz, Muhammad
    Lee, Wade M.
    Mohyuddin, Gbulam Rehman
    Prouty, Megan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 86 (06) : 1403 - 1405
  • [2] Homoeopathic remedies in dermatology: a systematic review of controlled clinical trials
    Simonart, T.
    Kabagabo, C.
    De Maertelaer, V.
    BRITISH JOURNAL OF DERMATOLOGY, 2011, 165 (04) : 897 - 905
  • [3] Assessment of Changes in Diversity in Dermatology Clinical Trials Between 2010-2015 and 2015-2020 A Systematic Review
    Chen, Vivien
    Akhtar, Shifa
    Zheng, Caiwei
    Kumaresan, Vignesh
    Nouri, Keyvan
    JAMA DERMATOLOGY, 2022, 158 (03) : 288 - 292
  • [4] Analyzing the Racial Diversity of Clinical Trials in IBD: A Systematic Review
    Garcia, Alexander
    Singh, Avneet
    Jover, Queenzy
    Abidi, Zehara
    Shakeel, Aleeza
    Thakkar, Anand
    Hunter, Krystal
    Morales, Stephanie Rivera
    Contino, Krysta
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S844 - S845
  • [5] Diversity in autoimmune blistering disease clinical trials: a systematic review
    Cole, Connor
    Haber, Roger
    Amber, Kyle T.
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2023, 62 (10) : E561 - E562
  • [6] Diversity in pulmonary rehabilitation clinical trials: a systematic review of the literature
    Chopra, Sunaina
    Rana, Shivani
    Patel, Reenal
    Hamilton, Tessa
    Dalip, Alyssa
    Malhi, Paramvir
    Camp, Pat G.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2024, 18 (1-2) : 49 - 58
  • [7] The Dermatology Life Quality Index as the primary outcome in randomized clinical trials: a systematic review
    Johns, Jeffrey R.
    Vyas, Jui
    Ali, Faraz M.
    Ingram, John R.
    Salek, Sam
    Finlay, Andrew Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 (04) : 497 - 507
  • [8] Diversity in randomized clinical trials for peripheral artery disease: a systematic review
    Chandler Long
    Abimbola O. Williams
    Alysha M. McGovern
    Caroline M. Jacobsen
    Liesl M. Hargens
    Sue Duval
    Michael R. Jaff
    International Journal for Equity in Health, 23
  • [9] Diversity Inclusion in Clinical Trials Investigating Esketamine for Depression: A Systematic Review
    Monahan, Katie
    Weyandt, Lisa
    Shepard, Emily
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2023, 31 (03) : 584 - 592
  • [10] Diversity in randomized clinical trials for peripheral artery disease: a systematic review
    Long, Chandler
    Williams, Abimbola O.
    Mcgovern, Alysha M.
    Jacobsen, Caroline M.
    Hargens, Liesl M.
    Duval, Sue
    Jaff, Michael R.
    INTERNATIONAL JOURNAL FOR EQUITY IN HEALTH, 2024, 23 (01)